We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routin... read more Featured Products: More products

Download Mobile App





Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 23 Jun 2021
Print article
Image: Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021 (Photo courtesy of Diagnostica Stago)
Image: Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021 (Photo courtesy of Diagnostica Stago)
Diagnostica Stago (Asnières-sur-Seine, France), which develops and markets automated systems for blood analysis, highlighted its Max Generation family of coagulation analyzers at MEDLAB Middle East 2021.

On display at the event was the STA R Max 3, a versatile analyzer that will adapt to any type of laboratory set-up, for an equivalent performance whether used alone or integrated into an automated track. It is supported by a range of reagents offering a comprehensive menu of routine and specialized tests, ensuring effective TAT (turnaround time) management. Like its predecessor, the STA R Max 3 has an EPC module for checking sample integrity that controls fill volumes of all types of tubes and detects haemolysed, icteric and lipemic samples to ensure quality results. It requires no additional plasma volume and does not affect throughput.

The company also presented the STA Compact Max 3 which offers significant performance improvements and includes the EPC (expert pre-analytical check) module. This EPC module controls fill volumes of all types of tubes and detects haemolysed, icteric and lipemic samples, allowing the STA Compact Max 3 to check sample integrity to ensure quality results. It requires no additional plasma volume and does not affect throughput. In addition, the company highlighted the STA Satellite Max which builds on the proven strengths of the Max Generation, offering new functionalities and a user-friendly interface, making it the ideal solution for Haemostasis testing in low-volume labs. The STA Satellite Max is a Haemostasis analyzer designed specifically for “satellite” labs looking for a device that meets their needs while guaranteeing results as reliable as those obtained in large specialized laboratories.

At this year’s MEDLAB Middle East, the company showcased the STA R Max 3, a versatile analyzer that will adapt to any type of laboratory set-up, for an equivalent performance whether used alone or integrated into an automated track. It is supported by a range of reagents offering a comprehensive menu of routine and specialized tests, ensuring effective TAT (turnaround time) management.

Related Links:
Diagnostica Stago

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.